We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Quest Launches BRCA Diagnostic, Files Preemptive Suit Against Myriad
Quest Launches BRCA Diagnostic, Files Preemptive Suit Against Myriad
October 18, 2013
Quest Diagnostics has jumped into the cancer diagnostic fray by launching a test used to predict the risk of breast and ovarian cancer